January 31, 2018

TAMM Xmas Team Photo 2017

We are grateful to have a growing talented team.
November 14, 2017

TAMM Net selected as FDA Consultant

Alzamend Neuro™ Launches Pursuit to Secure FDA IND and First Stage Clinicals. Company Selects TAMM Net as FDA Consultant to Lead Regulatory Actions for USF Treatment SALT […]
October 23, 2017

AxoGen, Inc. Receives David J. Gury Company of the Year Award from BioFlorida

Award recognizes company’s contribution to Florida’s life sciences industry ALACHUA, Fla., Oct. 18, 2017 (GLOBE NEWSWIRE) — AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and […]
April 26, 2017

Stimwave LLC Awarded DAPA

Fort Lauderdale, FL, February 2017.  Stimwave, LLC a manufacturer of The Freedom Stimulator is the smallest implanted stimulator system, was awarded a distribution and pricing agreement […]
April 1, 2017

Unique Device Identifier – Post Marketing Surveillance

CDRH:  Strategic Priorities:  Establishing a National Evaluation System GOAL #1:  Increase access of real-world evidence to support regulatory decisions. Measurements for 2016-2017:  Gain access to 25 […]
March 15, 2017

Differences in the Controls Between Class I

The distinguishing factor between whether a device can be designated as a Class I, Class II, or Class III device is based on the safety and […]
March 1, 2017

Sponsored Prior Authorization Services

Several large manufacturers currently offer prior authorization services for certain product lines. Why would they do this given the cost and regulatory exposure? Obviously, they believe […]
February 13, 2017

Strategic Classification of Your New Medical Device Technology

Never is it too soon to contemplate the regulatory strategy of a new medical device technology.  Several considerations should be considered early in the strategic development […]
December 12, 2016

Tamm Net at Bio Florida

Full session at #BioFL16 to learn about creative approaches to funding with TammNet!